Do you think the recent price rise is in anticipation for the revised study? It's a bit frustrating because I haven't loaded up as much as I want to haha
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025